(Q45182939)

English

TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer

scientific article published on 16 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer (English)

1 reference

Europe PubMed Central

10 December 2017

cancer-associated fibroblast

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Busch

1

1 reference

Europe PubMed Central

10 December 2017

A Acar

2

1 reference

Europe PubMed Central

10 December 2017

Y Magnusson

3

1 reference

Europe PubMed Central

10 December 2017

P Gregersson

4

1 reference

Europe PubMed Central

10 December 2017

L Rydén

5

1 reference

Europe PubMed Central

10 December 2017

G Landberg

6

1 reference

Europe PubMed Central

10 December 2017

language of work or name

0 references

publication date

16 December 2013

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

34

1 reference

Europe PubMed Central

10 December 2017

1

1 reference

Europe PubMed Central

10 December 2017

27-38

1 reference

Europe PubMed Central

10 December 2017

https://scigraph.springernature.com/pub.10.1038/onc.2013.527

0 references

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

TGFbeta in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Stromal myofibroblasts are drivers of invasive cancer growth

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Role of tissue stroma in cancer cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Stromal fibroblasts in cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Friends or foes - bipolar effects of the tumour stroma in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Lentivirus-delivered stable gene silencing by RNAi in primary cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

21 January 2018

Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

31 March 2020

Identification of fibroblast heterogeneity in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.527

31 March 2020

Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24336330

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/ONC.2013.527

1 reference

Europe PubMed Central

10 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45182939&oldid=2164730443"